Form 8-K - Current report:
SEC Accession No. 0001558370-23-016326
Filing Date
2023-10-10
Accepted
2023-10-10 16:24:00
Documents
16
Period of Report
2023-10-09
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fbio-20231009x8k.htm   iXBRL 8-K 48841
2 EX-3.1 fbio-20231009xex3d1.htm EX-3.1 12177
3 EX-99.1 fbio-20231009xex99d1.htm EX-99.1 14466
4 GRAPHIC fbio-20231009xex99d1001.jpg GRAPHIC 12419
  Complete submission text file 0001558370-23-016326.txt   264967

Data Files

Seq Description Document Type Size
5 EX-101.SCH fbio-20231009.xsd EX-101.SCH 4464
6 EX-101.DEF fbio-20231009_def.xml EX-101.DEF 15290
7 EX-101.LAB fbio-20231009_lab.xml EX-101.LAB 17715
8 EX-101.PRE fbio-20231009_pre.xml EX-101.PRE 15367
10 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20231009x8k_htm.xml XML 7406
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35366 | Film No.: 231318282
SIC: 2834 Pharmaceutical Preparations